Area of research
Psychiatry and Mental health · Cognitive Neuroscience
Research interest
Research focused on Frontotemporal dementia and Double blind, with related work in Dementia, Disease, Randomized controlled trial. Notable publications include 'Efficacy and safety of tau-aggregation inhibitor therapy in patients with mild or moderate Alzheimer's disease: a randomised, controlled, double-blind, parallel-arm, phase 3 trial', 'Potential of Low Dose Leuco-Methylthioninium Bis(Hydromethanesulphonate) (LMTM) Monotherapy for Treatment of Mild Alzheimer’s Disease: Cohort Analysis as Modified Primary Outcome...', and 'Degeneration of basal and limbic networks is a core feature of behavioural variant frontotemporal dementia'.
Degeneration of basal and limbic networks is a core feature of behavioural variant frontotemporal dementia
Potential of Low Dose Leuco-Methylthioninium Bis(Hydromethanesulphonate) (LMTM) Monotherapy for Treatment of Mild Alzheimer’s Disease: Cohort Analysis as Modified Primary Outcome in a Phase III Clinical Trial
Efficacy and safety of tau-aggregation inhibitor therapy in patients with mild or moderate Alzheimer's disease: a randomised, controlled, double-blind, parallel-arm, phase 3 trial